APA (7th ed.) Citation

Cournoyer, L., Liu, Y., Jaroch, D. B., Hullinger, T. G., Cox, B. F., Katz, S. C., . . . Guha, P. (2025). Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models. Frontiers in oncology, 15, 1655794. https://doi.org/10.3389/fonc.2025.1655794

Chicago Style (17th ed.) Citation

Cournoyer, Lauren, et al. "Pressure Enabled Drug Delivery (PEDD) of Nelitolimod Increased Therapeutic Delivery, Reduced Immunosuppression, and Improved Efficacy in Porcine and Murine Liver Tumor Models." Frontiers in Oncology 15 (2025): 1655794. https://doi.org/10.3389/fonc.2025.1655794.

MLA (9th ed.) Citation

Cournoyer, Lauren, et al. "Pressure Enabled Drug Delivery (PEDD) of Nelitolimod Increased Therapeutic Delivery, Reduced Immunosuppression, and Improved Efficacy in Porcine and Murine Liver Tumor Models." Frontiers in Oncology, vol. 15, 2025, p. 1655794, https://doi.org/10.3389/fonc.2025.1655794.